Clin2
NCT07570758Possibly a fitRecruiting

Testing ERX1000 to Help Adults Manage Obesity

Obesity & Overweight

Part of Hormones & metabolism clinical trials.

This study tests whether a new medication called ERX1000 is safe and well-tolerated in adults with obesity. The trial will help doctors understand if this treatment could be helpful for weight management.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Be between 18 and 60 years old
  • Have a BMI (body mass index) between 30 and 50, indicating overweight or obesity
  • Have kept your weight stable (within 5%) for the past 3 months
  • Not be pregnant, nursing, or planning to become pregnant during the study
  • Not have uncontrolled diabetes, serious heart problems, liver or kidney disease, or severe mental health conditions
  • Not be taking obesity medications like Wegovy, Saxenda, or Zepbound in the past 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07378033Enrolling by invitation
Body fat reduction and weight management study

This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.

Bangalore, Karnataka
NCT07652047Recruiting· Phase 1
Safety Study of CX11 Tablets for Weight Management

This study tests whether a new medication called CX11 is safe and well-tolerated at different doses in people with overweight or obesity. The goal is to understand how the body responds to the drug before larger trials test whether it helps with weight loss.

Las Vegas, Nevada
NCT07142707Recruiting· Phase 1
Testing a new obesity drug for safety and effects

This study tests an investigational medication called MBX 4291 for adults with obesity. It aims to see if the drug is safe and how it works in the body, which could lead to a new weight-loss treatment option.

Doral, Florida
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui
NCT06606483Not yet recruiting· Phase 2
Study of MDR-001 in adults with obesity or overweight

This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.

Hefei, Anhui

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.